STAAR Surgical beats Q1 expectations with adjusted EPS $0.38 on revenue of $93.5 million
- Analyst expectations were $0.13 per share adjusted EPS, compared with reported $0.38 per share.
- Q1 2026 net sales were $93.5 million and EPS was $0.10.
- The company returned to profitability in Q1 2026 while topping consensus expectations.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.